Personalized mRNA vaccine targets osteosarcoma relapse in first human use

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer ...

Pfizer didn't say hantavirus is side effect of its COVID-19 vaccine, contrary to online claims

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.

A New Hantavirus Vaccine Is in the Works

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising ...

When vaccine research is silenced, Americans pay the price | GUEST COMMENTARY

Opinion: The Trump administration’s recent censorship of vaccine research sets a dangerous precedent, writes A.J. Russo.

A new approach to cancer vaccination yields more powerful T cells

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious ...

COVID pioneer BioNTech: The fall of Germany's pandemic hero

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...

Doctors Say Hantavirus Is 'More Forgiving' Than COVID-19—Here's What That Means Exactly

With the recent contractions of hantavirus on a cruise ship, many are wondering how hantavirus differs from COVID-19.

Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.
The Manila Times

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for ...